These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38608411)

  • 1. Cancer stem cells biomarkers and the dynamics of the tumor microenvironment in oral squamous cell carcinoma.
    Perumal MKK; Renuka RR; Srinivasan GP; Jothinathan MKD
    Oral Oncol; 2024 May; 152():106797. PubMed ID: 38608411
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.
    Feng J; Li Y; Wen N
    Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
    Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
    J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
    Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
    Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44
    de Andrade NP; Rodrigues MF; Rodini CO; Nunes FD
    Pathol Res Pract; 2017 Mar; 213(3):235-244. PubMed ID: 28214216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte-tumor cell native encounter in oral squamous cell carcinoma.
    Sarode SC; Sarode GS; Sengupta N; Sharma NK; Patil S
    Future Oncol; 2020 Aug; 16(24):1793-1796. PubMed ID: 32539566
    [No Abstract]   [Full Text] [Related]  

  • 7. H⁺-myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinoma.
    Lee DG; Lee JH; Choi BK; Kim MJ; Kim SM; Kim KS; Chang K; Park SH; Bae YS; Kwon BS
    Curr Cancer Drug Targets; 2011 Oct; 11(8):966-75. PubMed ID: 21861841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function.
    Chowdhury FN; Reisinger J; Gomez KE; Chimed TS; Thomas CM; Le PN; Miller B; Morton JJ; Nieto CM; Somerset HL; Wang XJ; Keysar SB; Jimeno A
    Oral Oncol; 2019 Nov; 98():118-124. PubMed ID: 31586893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma.
    Baillie R; Itinteang T; Yu HH; Brasch HD; Davis PF; Tan ST
    J Clin Pathol; 2016 Aug; 69(8):742-4. PubMed ID: 27095085
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
    Mohanta S; Sekhar Khora S; Suresh A
    Arch Oral Biol; 2019 Mar; 99():92-106. PubMed ID: 30641296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative cancer stem cells are present in surgical margins of oral squamous cell carcinoma.
    Lazarevic M; Milosevic M; Trisic D; Toljic B; Simonovic J; Nikolic N; Mikovic N; Jelovac D; Petrovic M; Vukadinovic M; Milasin J
    J BUON; 2018; 23(6):1686-1692. PubMed ID: 30610795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
    Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
    Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and phenotypic characterization of side population cells in oral squamous cell carcinoma.
    Liu Y; Cui P; Chen J; Li W
    Mol Med Rep; 2015 May; 11(5):3642-6. PubMed ID: 25544110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell immunophenotypes in oral squamous cell carcinoma.
    Oliveira LR; Oliveira-Costa JP; Araujo IM; Soave DF; Zanetti JS; Soares FA; Zucoloto S; Ribeiro-Silva A
    J Oral Pathol Med; 2011 Feb; 40(2):135-42. PubMed ID: 21073537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple drug resistant, tumorigenic stem-like cells in oral cancer.
    Richard V; Sebastian P; Nair MG; Nair SN; Malieckal TT; Santhosh Kumar TR; Pillai MR
    Cancer Lett; 2013 Sep; 338(2):300-16. PubMed ID: 23791883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HSBP1 is associated with resistance to radiotherapy in oral squamous epithelial carcinoma.
    Shen L; Zhang R; Sun Y; Wang X; Deng AM; Bi L
    Med Oncol; 2014 Jun; 31(6):990. PubMed ID: 24816843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CIP2A in oral squamous cell carcinoma.
    Basile JR; Czerninski R
    Cancer Biol Ther; 2010 Oct; 10(7):700-2. PubMed ID: 20729627
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma.
    Harris K; Gelberg HB; Kiupel M; Helfand SC
    Vet Pathol; 2019 Nov; 56(6):826-839. PubMed ID: 31331247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic biomarkers in oral squamous cell carcinoma: A systematic review.
    Rivera C; Oliveira AK; Costa RAP; De Rossi T; Paes Leme AF
    Oral Oncol; 2017 Sep; 72():38-47. PubMed ID: 28797460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.